Home LiteratureArticle Details
PMID: 3462697 Published · ppublish English Journal Article

Reaction of nucleic acids and cis-diamminedichloroplatinum(II) in the presence of intercalating agents.

Malinge JM, Leng M

Abstract

The reaction of cis-diamminedichloroplatinum(II) and several synthetic or natural double-stranded polydeoxyribonucleotides has been carried out in the presence of such intercalating agents as ethidium bromide, proflavine, and acridine. After incubation of the reaction mixtures at 37 degrees C for 24 hr, some ethidium or proflavine, but no acridine, molecules are tightly bound to nucleic acids. Tight binding is defined by resistance to extraction with butanol, assayed by filtration at acid pH or by thin-layer chromatography at basic pH. In the ternary complexes, there is about one tightly bound ethidium (or proflavine) per platinum residue. At 37 degrees C, but not at 4 degrees C, tightly bound ethidium exchanges with free ethidium, whereas platinum residues do not exchange. The binding and the release of tightly bound ethidium are very slow (several hours). It is suggested that in the ternary complexes, nucleic acid-cis-Pt(NH3)2-intercalating agent, a bidentate adduct (guanine-ethidium or -proflavine)-cis-Pt(NH3)2, is formed. No tightly bound ethidium or proflavine is found when cis-diamminedichloroplatinum(II) is replaced by trans-diamminedichloroplatinum(II). Competition experiments between cis-diamminedichloroplatinum(II), poly(dG-dC), and poly(dG)-poly(dC) or poly(dA-dT) show that the presence of ethidium bromide, proflavine, or acridine interferes with the distribution of platinum between the polynucleotides. These results might help to explain the synergism for drugs used in combination with cis-diamminedichloroplatinum(II) and in the design of new chemotherapeutic agents.

MeSH Terms
Acridines Cisplatin Ethidium Guanine Intercalating Agents Nucleic Acid Conformation Nucleic Acids Polydeoxyribonucleotides Proflavine
Chemicals
Acridines Intercalating Agents Nucleic Acids Polydeoxyribonucleotides poly(dC-dG) Guanine Proflavine Ethidium Cisplatin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Malinge J M
Leng M
References (20)
20 references, click to expand
  1. New chemistry of an old molecule: cis-[Pt(NH3)2Cl2].
    Science. 1982 Dec 10;218(4577):1075-82 PMID: 6890712
  2. Ethidium bromide changes the nuclease-sensitive DNA binding sites of the antitumor drug cis-diamminedichloroplatinum(II).
    Proc Natl Acad Sci U S A. 1982 Jun;79(11):3489-92 PMID: 6954494
  3. Ethidium bromide alters the binding mode of cis-diamminedichloroplatinum(II) to pBR322 DNA.
    Cold Spring Harb Symp Quant Biol. 1983;47 Pt 1:355-60 PMID: 6345059
  4. Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).
    Biochemistry. 1983 Aug 2;22(16):3927-33 PMID: 6225458
  5. Reaction of cis-diamminedichloroplatinum (II) and DNA in B or Z conformation.
    EMBO J. 1984 Jun;3(6):1273-9 PMID: 6540171
  6. Immunological and spectroscopic studies of poly(dG-dC).poly(dG-dC) modified by cis-diamminedichloroplatinum(II).
    Nucleic Acids Res. 1984 Jul 25;12(14):5767-78 PMID: 6540440
  7. The chemistry and biology of left-handed Z-DNA.
    Annu Rev Biochem. 1984;53:791-846 PMID: 6383204
  8. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
    Biochemistry. 1985 Jan 29;24(3):707-13 PMID: 4039603
  9. Left-handed Z-DNA.
    Biochim Biophys Acta. 1985 Aug 21;825(4):339-44 PMID: 3893546
  10. Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).
    Proc Natl Acad Sci U S A. 1985 Jul;82(14):4616-9 PMID: 3895221
  11. Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA.
    Biochim Biophys Acta. 1985;780(3):167-80 PMID: 3896310
  12. Interstrand cross-links and sequence specificity in the reaction of cis-dichloro(ethylenediamine)platinum(II) with DNA.
    Biochemistry. 1985 Sep 10;24(19):5027-32 PMID: 4074675
  13. Comparison between poly(dG-dC).poly(dG-dC) and DNA modified by cis-diamminedichloroplatinum (II): immunological and spectroscopic studies.
    J Biomol Struct Dyn. 1985 Oct;3(2):363-75 PMID: 3917027
  14. Specific binding of antitumour drug cis-Pt(NH3)2C12 to DNA rich in guanine and cytosine.
    Nature. 1974 Oct 25;251(5477):736-7 PMID: 4427676
  15. Resolution of alpha, beta and gamma DNA of Saccharomyces cerevisiae with the antitumor drug cis-Pt (NH3)2CL2. Evidence for preferential drug binding by GpG sequences of DNA.
    J Mol Biol. 1976 Jul 15;104(4):793-801 PMID: 785014
  16. The mechanism of action of antitumor platinum compounds.
    Prog Nucleic Acid Res Mol Biol. 1979;22:71-133 PMID: 392602
  17. Use of exonuclease III to determine the site of stable lesions in defined sequences of DNA: the cyclobutane pyrimidine dimer and cis and trans dichlorodiammine platinum II examples.
    Nucleic Acids Res. 1981 Sep 25;9(18):4595-609 PMID: 6272211
  18. The B goes to Z transition of poly(dG-dC) . poly(dG-dC) modified by some platinum derivatives.
    Nucleic Acids Res. 1981 Nov 11;9(21):5659-69 PMID: 7198223
  19. Binding of [(dien)PtCl] Cl to poly(dG-dC)-poly(dG-dC) facilitates the B goes to Z conformational transition.
    Nucleic Acids Res. 1982 Jun 11;10(11):3573-88 PMID: 7201636
  20. Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.
    Cancer Res. 1983 Aug;43(8):3609-13 PMID: 6683124
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1986-09-00
Pages
6317-21
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC386494
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]